Delivery Order SPE2DB24D1104-SPE2DB25FXYF7
Award Date
3/3/25
Potential Completion Date
3/4/25
Potential Value
$26K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,275.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablets of 250 mg Abiraterone Acetate, a medication used in the treatment of prostate cancer. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 21, 2023. It is not designated as a...
This federal contract award, valued at $27,252.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Abiraterone Acetate 250 mg tablets, a prescription medication used to treat prostate cancer. The contract is a Firm Fixed Price Delivery Order that runs through January 8, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,968.55 Firm Fixed Price delivery order contract is for the supply of Abiraterone Acetate 500 mg tablets, a medication used in the treatment of prostate cancer. The contract has an ultimate completion date of January 13, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Abiraterone Acetate 250 mg tablets, a medication used in the treatment of prostate cancer. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,835.88 and a period of performance through February 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,402.91, is a Firm Fixed Price Delivery Order for the supply of Abiraterone Acetate 500 mg tablets. The contract has an ultimate completion date of February 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,262.07, is for the delivery of abiraterone acetate 500 mg tablets. The contract is a delivery order with a firm fixed price and has an ultimate completion date of December 12, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This federal contract award, valued at $6,377.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of 4566544785 - ABIRATERONE ACETATE 500 MG TAB 60S, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 26, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This federal contract award is for the delivery of Abiraterone Acetate 250 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,546.31, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,747.20, is for the delivery of abiraterone acetate 250 mg tablets. It is a firm fixed-price delivery order contract with a completion date of February 21, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,355.49 firm fixed-price delivery order is for the supply of 4562894544 | ABIRATERONE ACETATE 500 MG TAB 60S. The contract has an ultimate completion date of November 27, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with the DLA Troop Support...